Kala Pharmaceuticals, Inc. (KALA)

USD 3.75

(0.81%)

Gross Profit Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual gross profit in 2023 was -303 Thousand USD , down -122.75% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly gross profit in 2024 Q1 was -66 Thousand USD , down 0.0% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a annual gross profit of 1.33 Million USD in annual gross profit 2022, down -81.35% from previous year.
  • Kala Pharmaceuticals, Inc. reported a annual gross profit of 7.14 Million USD in annual gross profit 2021, up 123.99% from previous year.
  • Kala Pharmaceuticals, Inc. reported a quarterly gross profit of -66 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a quarterly gross profit of - USD for 2023 Q4, up 100.0% from previous quarter.

Annual Gross Profit Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Gross Profit of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Gross Profit Gross Profit Growth
2023 -303 Thousand USD -122.75%
2022 1.33 Million USD -81.35%
2021 7.14 Million USD 123.99%
2020 3.18 Million USD -21.57%
2019 4.06 Million USD 525.76%
2018 -955 Thousand USD -48.52%
2017 -643 Thousand USD -116.5%
2016 -297 Thousand USD -760.0%
2015 45 Thousand USD 0.0%

Peer Gross Profit Comparison of Kala Pharmaceuticals, Inc.

Name Gross Profit Gross Profit Difference
ANI Pharmaceuticals, Inc. 305.3 Million USD 100.099%
Aquestive Therapeutics, Inc. 29.75 Million USD 101.018%
Collegium Pharmaceutical, Inc. 326.16 Million USD 100.093%
Cosmos Health Inc. 4.34 Million USD 106.966%
Cyclo Therapeutics, Inc. -2.41 Million USD 87.428%
Esperion Therapeutics, Inc. 73.06 Million USD 100.415%
Cronos Group Inc. 6.99 Million USD 104.334%
Incannex Healthcare Limited 12 Thousand USD 2625.0%
Lifecore Biomedical, Inc. 41.85 Million USD 100.724%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 59.361%
Sunshine Biopharma, Inc. 8.33 Million USD 103.633%
Sunshine Biopharma, Inc. 8.33 Million USD 103.633%
SCYNEXIS, Inc. 124.51 Million USD 100.243%
Safety Shot Inc -74.45 Thousand USD -306.946%
Theratechnologies Inc. 62.12 Million USD 100.488%
Alpha Teknova, Inc. 10.29 Million USD 102.943%
Universe Pharmaceuticals INC 10.07 Million USD 103.007%
Pacira BioSciences, Inc. 490.3 Million USD 100.062%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD 106.386%
Dynavax Technologies Corporation 182.11 Million USD 100.166%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 100.069%
Radius Health, Inc. 307.71 Million USD 100.098%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD 154.696%
Alvotech -69.42 Million USD 99.564%
Intra-Cellular Therapies, Inc. 430.62 Million USD 100.07%
SIGA Technologies, Inc. 122.09 Million USD 100.248%
Shineco, Inc. 882.16 Thousand USD 134.347%
Silver Spike Investment Corp. 8.1 Million USD 103.74%
Journey Medical Corporation 52.52 Million USD 100.577%
Petros Pharmaceuticals, Inc. 4.19 Million USD 107.229%
Embecta Corp. 749.9 Million USD 100.04%
Harrow Health, Inc. 90.55 Million USD 100.335%
Procaps Group, S.A. 239.56 Million USD 100.126%
Biofrontera Inc. 16.62 Million USD 101.822%
DURECT Corporation 6.83 Million USD 104.436%
PainReform Ltd. -15 Thousand USD -1920.0%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 100.058%
OptiNose, Inc. 62.35 Million USD 100.486%
RedHill Biopharma Ltd. 3.05 Million USD 109.921%
Organogenesis Holdings Inc. 309.79 Million USD 100.098%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 100.905%
ProPhase Labs, Inc. 16.23 Million USD 101.866%
Phibro Animal Health Corporation 312.48 Million USD 100.097%
Procaps Group S.A. 239.56 Million USD 100.126%
TherapeuticsMD, Inc. 1.3 Million USD 123.272%
Viatris Inc. 6.43 Billion USD 100.005%
Rockwell Medical, Inc. 8.7 Million USD 103.481%
Aytu BioPharma, Inc. 54.58 Million USD 100.555%
Tilray Brands, Inc. 223.35 Million USD 100.136%
PetIQ, Inc. 252.74 Million USD 100.12%
Talphera, Inc. -4.89 Million USD 93.81%
Neurocrine Biosciences, Inc. 1.84 Billion USD 100.016%
Alimera Sciences, Inc. 61.17 Million USD 100.495%
Assertio Holdings, Inc. 125.04 Million USD 100.242%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD -4348.686%
Avadel Pharmaceuticals plc 27.11 Million USD 101.117%
Hempacco Co., Inc. -1.21 Million USD 75.079%
Alvotech -69.42 Million USD 99.564%
Lantheus Holdings, Inc. 709.54 Million USD 100.043%
Kamada Ltd. 52.59 Million USD 100.576%
Currenc Group, Inc. 17.35 Million USD 101.746%
Indivior PLC 907 Million USD 100.033%
Evoke Pharma, Inc. 4.97 Million USD 106.086%
Flora Growth Corp. 17.73 Million USD 101.708%
Cyclo Therapeutics, Inc. -2.41 Million USD 87.428%
Evolus, Inc. 140.52 Million USD 100.216%
HUTCHMED (China) Limited 453.55 Million USD 100.067%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 100.088%
Akanda Corp. 111.44 Thousand USD 371.873%